NONATO ESPRITU PINEDA

Allopathic & Osteopathic Physicians|Internal Medicine LAKEHURST, NJ NPI 1548229891

General Payments — all program years on this page

$2,731.78

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 167
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $336.88 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $336.8820

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $436.6433
2019 $395.4622
2020 $177.2813
2021 $343.4324
2022 $608.2935
2023 $433.8020
2024 $336.8820

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087235271 Novartis Pharmaceuticals Corporation $15.77 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092264640 Boston Scientific Corporation $41.43 08/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096792460 Novo Nordisk Inc $15.76 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104348206 AstraZeneca Pharmaceuticals LP $15.63 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104451784 AstraZeneca Pharmaceuticals LP $14.44 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105271038 ABBVIE INC. $13.29 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105460624 AstraZeneca Pharmaceuticals LP $15.55 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105508002 AstraZeneca Pharmaceuticals LP $14.55 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105529018 AstraZeneca Pharmaceuticals LP $14.30 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105723125 AstraZeneca Pharmaceuticals LP $16.60 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110770693 Eisai Inc. $15.51 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116204763 GlaxoSmithKline, LLC. $14.00 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116623507 GlaxoSmithKline, LLC. $14.00 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116635316 GlaxoSmithKline, LLC. $13.51 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116698377 GlaxoSmithKline, LLC. $16.80 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118052281 Boehringer Ingelheim Pharmaceuticals, Inc. $15.72 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131074055 PFIZER INC. $16.88 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135293205 Lilly USA, LLC $15.33 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153326173 Dexcom, Inc. $24.01 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153491705 Salix Pharmaceuticals, a division of Bausch Health US, LLC $13.80 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.